SCHEMBL6588656

SCHEMBL6588656

CCOC(=O)N1c2cc(OC)c(OC)cc2C(N(Cc2ccc(Cl)cc2)C(=O)OC)CC1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 2/20 0.48
PDE4B Q07343 1/20 0.39
PDE4D Q08499 1/20 0.39
PTGDR2 Q9Y5Y4 2/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 4/20 0.37
NPSR1 Q6W5P4 2/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
OPRK1 P41145 2/20 0.35
OPRM1 P35372 1/20 0.35
LMNA P02545 1/20 0.35
HTR2A P28223 1/20 0.34
GAA P10253 1/20 0.34
NR1I2 O75469 1/20 0.34
MAOA P21397 1/20 0.34
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6588649 1.00 CETP (0.48) CETPPDE4BPDE4DPTGDR2KMT2A
SCHEMBL6588653 1.00 CETP (0.48) CETPPDE4BPDE4DPTGDR2KMT2A
SCHEMBL6592150 0.93 CETP (0.49) CETPPTGDR2KMT2AMEN1ALDH1A1
SCHEMBL6592155 0.93 CETP (0.49) CETPPTGDR2KMT2AMEN1ALDH1A1
SCHEMBL6592159 0.93 CETP (0.49) CETPPTGDR2KMT2AMEN1ALDH1A1
SCHEMBL992955 0.92 CETP (0.49) CETPPDE4BPDE4DPTGDR2KMT2A
SCHEMBL6594744 0.92 CETP (0.49) CETPPTGDR2KMT2AMEN1ALDH1A1
SCHEMBL6594741 0.92 CETP (0.49) CETPPTGDR2KMT2AMEN1ALDH1A1
SCHEMBL6594748 0.92 CETP (0.49) CETPPTGDR2KMT2AMEN1ALDH1A1
SCHEMBL6594430 0.92 CETP (0.49) CETPPDE4BPDE4DPTGDR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0987251-B1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors PFIZER PROD INC (US) 2004-05-19 EP disclosed
US-6362198-B1 ANTICHOLESTEROL, ANTILIPEMIC AGENT PFIZER INC. 2002-03-26 US disclosed
US-6140342-A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR; USED TO ELEVATE CERTAIN PLASMA LIPID LEVELS, INCLUDING HIGH DENSITY LIPOPROTEIN-CHOLESTEROL AND TO LOWER CERTAIN OTHER PLASMA LIPID LEVELS, SUCH AS LDL-CHOLESTEROL AND TRIGLYCERIDES PFIZER INC. (US) 2000-10-31 US disclosed
EP-0987251-A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors Pfizer Products Inc. (US) 2000-03-22 EP disclosed